We are live on !
Find out more
Emerald Advisers Portfolio holdings
AUM
$4.25B
Turnover
24.28%
1-Year Est. Return
141.71%
This Fund
S&P 500
This Quarter Est. Return
+50.94%
1 Year Est. Return
+141.71%
3 Year Est. Return
+486.97%
5 Year Est. Return
+675.33%
10 Year Est. Return
+5,134.29%
AUM
$4.25B
AUM Growth
+$1.09B
(+34%)
Cap. Flow
-$109M
Cap. Flow % of AUM
Cap. Flow %
-2.57%
Top 10 Holdings %
Top 10 Hldgs %
17.4%
Holding
276
New
28
Increased
80
Reduced
84
Closed
39
Avg Time Held
2.5
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Legence Corp
LGN
|
+$53.3M |
| 2 |
Sensient Technologies
SXT
|
+$43.9M |
| 3 |
InterDigital
IDCC
|
+$35.5M |
| 4 |
Axcelis
ACLS
|
+$34.7M |
| 5 |
Terex
TEX
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bloom Energy
BE
|
+$137M |
| 2 |
Credo Technology Group
CRDO
|
+$94.7M |
| 3 |
TTM Technologies
TTMI
|
+$85.3M |
| 4 |
Fabrinet
FN
|
+$68.7M |
| 5 |
Sterling Infrastructure
STRL
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.23% |
| 2 | Industrials | 23.28% |
| 3 | Healthcare | 21.93% |
| 4 | Financials | 9.1% |
| 5 | Consumer Discretionary | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
LendingTree
TREE
$376M
| $14.8M | 0.35% |
334,702
-4,967
| -1% | -$201K |
2024 Q1
9 quarters
|
|
102
WesBanco
WSBC
$3.75B
| $14.8M | 0.35% |
379,586
+378,721
| +43,783% | +$13.3M |
2025 Q1
5 quarters
|
|
103
Aveanna Healthcare
AVAH
$2.92B
| $14.1M | 0.33% |
1,642,406
-48,051
| -3% | -$339K |
2025 Q4
2 quarters
|
|
104
Trinity Capital Inc
TRIN
$1.55B
| $13.3M | 0.31% |
744,877
-21,313
| -3% | -$352K |
2021 Q1
21 quarters
|
|
105
WhiteHawk Minerals Corp
WHK
$681M
| $11.6M | 0.27% |
+417,311
| New | +$11.3M |
2026 Q2
0 quarters
|
|
106
NVIDIA
NVDA
$5.09T
| $11.4M | 0.27% |
57,148
+5,227
| +10% | +$1.07M |
2017 Q4
34 quarters
|
|
107
AEVEX Corp
AVEX
$749M
| $11.3M | 0.26% |
+538,568
| New | +$14M |
2026 Q2
0 quarters
|
|
108
Corvus Pharmaceuticals
CRVS
$886M
| $10.2M | 0.24% |
685,683
-533
| -0.1% | -$7.4K |
2026 Q1
1 quarter
|
|
109
Dave Inc
DAVE
$4.52B
| $10.1M | 0.24% |
+26,993
| New | +$7.02M |
2026 Q2
0 quarters
|
|
110
Viridian Therapeutics
VRDN
$2.53B
| $9.9M | 0.23% |
+537,328
| New | +$8.66M |
2026 Q2
0 quarters
|
|
111
Definium Therapeutics
DFTX
$4.79B
| $8.41M | 0.2% |
+178,751
| New | +$4.42M |
2026 Q2
0 quarters
|
|
112
Ambarella
AMBA
$2.94B
| $8.28M | 0.19% |
+96,501
| New | +$6.64M |
2026 Q2
0 quarters
|
|
113
Flowco Holdings
FLOC
$863M
| $8.15M | 0.19% |
382,062
-4,873
| -1% | -$116K |
2026 Q1
1 quarter
|
|
114
Wave Life Sciences
WVE
$627M
| $7.11M | 0.17% |
1,223,965
-37,218
| -3% | -$247K |
2024 Q2
8 quarters
|
|
115
Metallus
MTUS
$846M
| $6.85M | 0.16% |
366,351
-9,783
| -3% | -$184K |
2026 Q1
1 quarter
|
|
116
HawkEye 360 Inc
HAWK
$1.2B
| $6.56M | 0.15% |
+324,464
| New | +$8.96M |
2026 Q2
0 quarters
|
|
117
Alphabet (Google) Class A
GOOGL
$3.92T
| $6.3M | 0.15% |
17,642
+1,622
| +10% | +$584K |
2015 Q4
42 quarters
|
|
118
Black Rock Coffee Bar Inc
BRCB
$218M
| $6.15M | 0.14% |
742,337
-7,289
| -1% | -$72.6K |
2025 Q3
3 quarters
|
|
119
Apple
AAPL
$5.07T
| $5.88M | 0.14% |
20,310
+691
| +4% | +$198K |
2013 Q2
52 quarters
|
|
|
120
Credo Technology Group
CRDO
$27.7B
| $5.27M | 0.12% |
19,362
-479,212
| -96% | -$94.7M |
2022 Q2
16 quarters
|
|
121
Microsoft
MSFT
$3.89T
| $4.81M | 0.11% |
12,893
-355
| -3% | -$144K |
2015 Q3
43 quarters
|
|
122
Heartflow Inc
HTFL
$4.93B
| $4.52M | 0.11% |
154,196
-67,106
| -30% | -$2.02M |
2025 Q3
3 quarters
|
|
123
Broadcom
AVGO
$1.54T
| $4.18M | 0.1% |
11,077
+239
| +2% | +$95.8K |
2024 Q1
9 quarters
|
|
|
EROC
124
ERock Inc
EROC
$385M
| $4.07M | 0.1% |
+280,734
| New | +$4.47M |
2026 Q2
0 quarters
|
|
125
MasTec
MTZ
$13.7B
| $3.32M | 0.08% |
7,983
-544
| -6% | -$208K |
2021 Q1
21 quarters
|
|
Similar funds
CAM
Emerald Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, Emerald Advisers held 276 positions worth $4.25B, up 34% from $3.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Emerald Advisers's Q2 2026 filing shows 28 new, 80 increased, 84 reduced and 39 closed positions. Its largest new stake was Legence Corp: 653,788 shares worth $55.7M. The largest sale was Bloom Energy, an estimated $137M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.
- Emerald Advisers's largest Q2 2026 buy was Legence Corp: 653,788 shares worth $55.7M.
- Emerald Advisers added most to InterDigital in Q2 2026, an estimated $35.5M increase.
- Emerald Advisers's biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $137M.
- Emerald Advisers fully exited BridgeBio Pharma in Q2 2026, selling an estimated $38.3M.
- Emerald Advisers's ten largest holdings make up 17% of its $4.25B portfolio in Q2 2026.
- Emerald Advisers opened 28 new positions and closed 39 in Q2 2026.
- Emerald Advisers's portfolio value rose 34% quarter-over-quarter to $4.25B.
Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.